Fresenius SE & Co. KGaA (OTCMKTS:FSNUY - Get Free Report) was the target of a significant growth in short interest in January. As of January 15th, there was short interest totalling 63,900 shares, a growth of 428.1% from the December 31st total of 12,100 shares. Based on an average daily trading volume, of 124,300 shares, the days-to-cover ratio is presently 0.5 days.
Fresenius SE & Co. KGaA Stock Down 1.3 %
Fresenius SE & Co. KGaA stock traded down $0.13 during trading on Friday, reaching $9.60. 37,697 shares of the company were exchanged, compared to its average volume of 82,726. The stock's 50 day simple moving average is $9.03 and its two-hundred day simple moving average is $9.03. The company has a debt-to-equity ratio of 0.57, a quick ratio of 1.05 and a current ratio of 1.36. Fresenius SE & Co. KGaA has a 52-week low of $6.57 and a 52-week high of $9.84.
Fresenius SE & Co. KGaA (OTCMKTS:FSNUY - Get Free Report) last posted its quarterly earnings results on Wednesday, November 6th. The company reported $0.19 EPS for the quarter. The company had revenue of $5.90 billion for the quarter. As a group, research analysts anticipate that Fresenius SE & Co. KGaA will post 0.79 earnings per share for the current fiscal year.
Analyst Upgrades and Downgrades
Separately, Citigroup upgraded Fresenius SE & Co. KGaA to a "strong-buy" rating in a research report on Friday, October 25th.
Check Out Our Latest Stock Report on Fresenius SE & Co. KGaA
Fresenius SE & Co. KGaA Company Profile
(
Get Free Report)
Fresenius SE & Co KGaA, a health care company, provides products and services for chronically ill patients. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure.
See Also
Before you consider Fresenius SE & Co. KGaA, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Fresenius SE & Co. KGaA wasn't on the list.
While Fresenius SE & Co. KGaA currently has a "Strong Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
